Effect of CD47 Blockade on Vascular Inflammation.
作者信息
Jarr Kai-Uwe, Nakamoto Ryusuke, Doan Brandon H, Kojima Yoko, Weissman Irving L, Advani Ranjana H, Iagaru Andrei, Leeper Nicholas J
机构信息
Stanford University, Stanford, CA
出版信息
N Engl J Med. 2021 Jan 28;384(4):382-383. doi: 10.1056/NEJMc2029834.
Abstract
摘要
相似文献
1
Effect of CD47 Blockade on Vascular Inflammation.CD47阻断对血管炎症的影响。
N Engl J Med. 2021 Jan 28;384(4):382-383. doi: 10.1056/NEJMc2029834.
2
F-Fluorodeoxyglucose-Positron Emission Tomography Imaging Detects Response to Therapeutic Intervention and Plaque Vulnerability in a Murine Model of Advanced Atherosclerotic Disease-Brief Report.氟代脱氧葡萄糖正电子发射断层扫描成像检测在晚期动脉粥样硬化疾病的小鼠模型中治疗干预的反应和斑块易损性-简要报告。
Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2821-2828. doi: 10.1161/ATVBAHA.120.315239. Epub 2020 Oct 22.
3
Effect of Alirocumab on Carotid Inflammation by [F]FDG PET in Patients With Acute Myocardial Infarction.阿利西尤单抗对急性心肌梗死患者颈动脉炎症的[F]FDG PET成像影响
JACC Cardiovasc Imaging. 2024 Sep;17(9):1118-1120. doi: 10.1016/j.jcmg.2024.04.001. Epub 2024 Apr 10.
4
PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers.前蛋白转化酶枯草溶菌素9（PCSK9）抗体阿利西尤单抗可减轻动脉壁炎症，而不改变循环炎症标志物。
JACC Cardiovasc Imaging. 2019 Dec;12(12):2571-2573. doi: 10.1016/j.jcmg.2019.06.022. Epub 2019 Aug 14.
5
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.BMS-582949（一种 p38 丝裂原活化蛋白激酶（p38 MAPK）抑制剂）对动脉炎症的影响：一项多中心 FDG-PET 试验。
Atherosclerosis. 2015 Jun;240(2):490-6. doi: 10.1016/j.atherosclerosis.2015.03.039. Epub 2015 Mar 28.
6
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.CD47 免疫检查点阻断剂在抗肿瘤治疗中的研究进展：血液毒性方面
J Cancer Res Clin Oncol. 2022 Jan;148(1):1-14. doi: 10.1007/s00432-021-03815-z. Epub 2021 Oct 5.
7
Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.动脉粥样硬化炎症变化的影像学：多模态成像取得进展。
JACC Cardiovasc Imaging. 2011 Oct;4(10):1119-22. doi: 10.1016/j.jcmg.2011.09.001.
8
Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial.肿瘤坏死因子-α拮抗剂阿达木单抗对银屑病患者动脉炎症的影响：一项随机对照试验的结果。
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):83-90. doi: 10.1161/CIRCIMAGING.112.975730. Epub 2012 Nov 30.
9
Effect of Liraglutide on Arterial Inflammation Assessed as [F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.利拉鲁肽对 2 型糖尿病患者动脉炎症的影响：一项随机、双盲、安慰剂对照试验。
Circ Cardiovasc Imaging. 2021 Jul;14(7):e012174. doi: 10.1161/CIRCIMAGING.120.012174. Epub 2021 Jun 30.
10
Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.吡格列酮可减轻糖耐量受损或糖尿病患者的动脉粥样硬化斑块炎症：一项前瞻性、随机、对照研究，使用颈动脉和升主动脉的 FDG PET/CT 连续成像研究。
JACC Cardiovasc Imaging. 2011 Oct;4(10):1110-8. doi: 10.1016/j.jcmg.2011.08.007.
引用本文的文献
1
The impact of immune checkpoint inhibition on atherosclerosis in cancer patients.免疫检查点抑制对癌症患者动脉粥样硬化的影响。
Front Immunol. 2025 Jul 31;16:1604989. doi: 10.3389/fimmu.2025.1604989. eCollection 2025.
2
Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis.计算模型预测促吞噬细胞疗法对人类动脉粥样硬化的益处。
Circulation. 2025 Jul 22;152(3):208-211. doi: 10.1161/CIRCULATIONAHA.124.072676. Epub 2025 Jul 21.
3
Insights Into Heart-Tumor Interactions in Heart Failure.心力衰竭中心脏与肿瘤相互作用的见解
Circ Res. 2025 May 23;136(11):1262-1285. doi: 10.1161/CIRCRESAHA.124.325490. Epub 2025 May 22.
4
Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases.超越癌症：基于CD47的疗法在非癌症疾病中的潜在应用。
Acta Pharm Sin B. 2025 Feb;15(2):757-791. doi: 10.1016/j.apsb.2024.11.018. Epub 2024 Nov 28.
5
Ocular motor cranial neuropathy and risk of thyroid cancer: A Korean population-based study.动眼神经颅神经病变与甲状腺癌风险：一项基于韩国人群的研究。
PLoS One. 2025 Mar 12;20(3):e0319872. doi: 10.1371/journal.pone.0319872. eCollection 2025.
6
Immune checkpoint inhibitors and myocardial infarction.免疫检查点抑制剂与心肌梗死
J Thromb Thrombolysis. 2025 Mar 10. doi: 10.1007/s11239-025-03081-7.
7
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4Foxp3 Regulatory T Cell Immunosuppression.免疫检查点是调节心脑血管疾病和CD4Foxp3调节性T细胞免疫抑制的新治疗靶点。
Int J Drug Discov Pharm. 2024 Dec;3(4). doi: 10.53941/ijddp.2024.100022. Epub 2024 Nov 26.
8
Cardiovascular Disease and Cancer: A Dangerous Liaison.心血管疾病与癌症：一种危险的关联。
Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):359-371. doi: 10.1161/ATVBAHA.124.319863. Epub 2025 Jan 9.
9
Smooth muscle cell-specific CD47 deletion suppresses atherosclerosis.平滑肌细胞特异性CD47缺失可抑制动脉粥样硬化。
Life Sci. 2025 Jan 15;361:123315. doi: 10.1016/j.lfs.2024.123315. Epub 2024 Dec 13.
10
Chronic inflammation and vascular cell plasticity in atherosclerosis.动脉粥样硬化中的慢性炎症与血管细胞可塑性
Nat Cardiovasc Res. 2024 Dec;3(12):1408-1423. doi: 10.1038/s44161-024-00569-y. Epub 2024 Dec 9.
本文引用的文献
1
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.Hu5F9-G4 联合利妥昔单抗阻断 CD47 在非霍奇金淋巴瘤中的作用。
N Engl J Med. 2018 Nov 1;379(18):1711-1721. doi: 10.1056/NEJMoa1807315.
2
The Role of Efferocytosis in Atherosclerosis.胞葬作用在动脉粥样硬化中的作用。
Circulation. 2017 Jan 31;135(5):476-489. doi: 10.1161/CIRCULATIONAHA.116.025684.
3
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.抗CD47抗体可恢复吞噬作用并预防动脉粥样硬化。
Nature. 2016 Aug 4;536(7614):86-90. doi: 10.1038/nature18935. Epub 2016 Jul 20.
4
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.强化他汀类药物治疗可迅速降低动脉粥样硬化炎症：多中心氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描可行性研究结果。
J Am Coll Cardiol. 2013 Sep 3;62(10):909-17. doi: 10.1016/j.jacc.2013.04.066. Epub 2013 May 30.
5
Inflammation and atherosclerosis.炎症与动脉粥样硬化。
Circulation. 2002 Mar 5;105(9):1135-43. doi: 10.1161/hc0902.104353.
Zotero 插件